Pediatric Onset Systemic Lupus Erythematosus Complicated by Toxic Epidermal Necrolysis
A Rare Association
DOI:
https://doi.org/10.70552/pjaai.25.2.16199Keywords:
toxic epidermal necrolysis, systemic lupus erythematosus, pediatric SLE, toxic epidermal necrolysis in systemic lupus erythematosusAbstract
Toxic epidermal necrolysis (TEN) and systemic lupus erythematosus (SLE) rarely coexist in pediatric patients, posing significant diagnostic dilemma due to their overlapping clinical manifestations, particularly in the bullous subtype. We report a case of a 14-year-old female initially presenting with features suggestive of Bullous SLE, including generalized erythematous plaques and subsequent bullae formation, accompanied by systemic symptoms and positive serological markers for SLE. However, skin biopsy findings revealed characteristics consistent with TEN, precipitated by recent antibiotic administration for a urinary tract infection. Prompt cessation of offending medications and initiation of appropriate therapy led to clinical improvement. TEN in pediatric population with SLE is uncommon but possible occurrence. Thorough history including drug history, physical examination and proper work-up help differentiate these two or discover their coexistence.
References
Fan WY, Zhai QR, Ma QB, Ge HX. Toxic epidermal necrolysis with systemic lupus erythematosus: case report and review of the literature. Ann Palliat Med. 2021;11(6):2144-51. https://pubmed.ncbi.nlm.nih.gov/34412491 https://doi.org/10.21037/apm-21-341 DOI: https://doi.org/10.21037/apm-21-341
Shahidi‐Dadras M, Araghi F, Ahmadzadeh A, Rakhshan A, Tabary M, Dadkhahfar S. Ten/SJS‐like lupus erythematosus presentation complicated by COVID-19. Dermatol Ther. 2021;34(1):e14612. https://pubmed.ncbi.nlm.nih.gov/33258528 https://pmc.ncbi.nlm.nih.gov/articles/PMC7744967 https://doi.org/10.1111/dth.14612 DOI: https://doi.org/10.1111/dth.14612
Chaudhary H, Bhattarai D, Vignesh P, et al. 159 Pediatric onset lupus with stevens johnson syndrome/toxic epidermal necrolysis: an unusual association. Lupus Sci Med.. 2019;6. https://doi.org/10.1136/lupus-2019-lsm.159 DOI: https://doi.org/10.1136/lupus-2019-lsm.159
Rossi CM, Beretta FN, Traverso G, Mancarella S. A case report of toxic epidermal necrolysis (TEN) in a patient with COVID-19 treated with hydroxychloroquine: are these two partners in crime?. Clin Mol Allergy. 2020; 18, 19. https://pubmed.ncbi.nlm.nih.gov/ 33033459 https://pmc.ncbi.nlm.nih.gov/articles/PMC7537980 https://doi.org/10.1186/s12948-020-00133-6 DOI: https://doi.org/10.1186/s12948-020-00133-6
Alajmin A, Jfri A, Gomolin A, Jafarian F. A pediatric case of Stevens-Johnson Syndrome/toxic epidermal necrolysis with rapid response to intravenous cyclosporine. JAAD Case Rep 2020; 6(6):555–7. https://pubmed.ncbi.nlm.nih.gov/32509946 https://pmc.ncbi.nlm.nih.gov/articles/PMC7265061 https://doi.org/10.1016/j.jdcr.2020.04.003 DOI: https://doi.org/10.1016/j.jdcr.2020.04.003
Capule F, Tragulpiankit P, Mahasirimongkol S, et al. Carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap in a Filipino with positive HLA-B75 serotype. BMJ Case. 2018;2018:bcr2018225028. https://pubmed.ncbi.nlm.nih.gov/30018035 PMCID: PMC6058113 https://doi.org/10.1136/bcr-2018-225028 DOI: https://doi.org/10.1136/bcr-2018-225028
Ubukata N, Nakatani E, Hashizume H, Sasaki H, Miyachi Y. Risk factors and drugs that trigger the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis: a population-based cohort study using the Shizuoka Kokuho database. JAAD Int. 2022;11:24-32. https://pubmed.ncbi.nlm.nih.gov/36818677 PMCID: PMC9932121 https://doi.org/ DOI: https://doi.org/10.1016/j.jdin.2022.12.002
1016/j.jdin.2022.12.002
Lee HY, Tey HL, Pang SM, Thirumoorthy T. Systemic lupus erythematosus presenting as Stevens–Johnson syndrome and toxic epidermal necrolysis: a report of three cases. Lupus. 2010;20(6):647-52. https://pubmed.ncbi.nlm.nih.gov/21148602 https://doi.org/ DOI: https://doi.org/10.1177/0961203310385162
1177/0961203310385162
Ahmed Eltahir NI, Elgenaid SN, Adam Essa ME, et al. Recurrent Stevens–Johnson syndrome in a patient with systemic lupus erythematosus: a case report. J Int Med Res. 2020;48(10):300060520964348. https://pubmed.ncbi.nlm.nih.gov/33086898 https://pmc.ncbi.nlm.nih.gov/articles/PMC7585900 https://doi.org/10.1177/0300060520964348 DOI: https://doi.org/10.1177/0300060520964348
Rutnin S, Chanprapaph K. Vesiculobullous diseases in relation to lupus erythematosus. Clin Cosmet Investig Dermatol. 2019;12:653-67
https://pubmed.ncbi.nlm.nih.gov/31564947 https://pmc.ncbi.nlm.nih.gov/articles/PMC6732903 https://doi.org/10.2147/CCID.S220906 DOI: https://doi.org/10.2147/CCID.S220906
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Roice Angel C. Caguioa, MD, Janelle G. Go, MD, Camelia Faye R. Tuazon, MD, Mary Grace Anne A. Calvarido, MD
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
